Muscarinic receptor agonists
US10428088B2 · kind B2 · utility
10Cited by
4References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 23, 2018 |
| Grant date | Oct 1, 2019 |
| Priority date | — |
| Expiry date | May 23, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compounds that are agonists of the muscarinic M1 receptor and which are useful in the treatment of muscarinic M1 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds provided are of formula where m, p, q, W, Z, Y, X1, X2, R1, R2, R3 and R4 are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.